Oncology & Cancer

NICE says 'not enough data' to approve drug for ovarian cancer

The National Institute for Health and Care Excellence (NICE) says it cannot give a positive decision over whether to recommend a new drug for ovarian cancer unless its makers provide more information on cost. A final decision ...

Addiction

More than 300 Poles taken ill after designer drug use

Police have detained nine people suspected of trafficking designer drugs after at least 317 Poles fell ill in recent days from taking the psychoactive substances, including dozens who remained hospitalised Wednesday.

Other

Court clears German safety body in breast implant scare

A French appeals court on Thursday cleared German safety standards body TUV of liability in a faulty breast implant scandal, meaning hundreds of women will have to pay back damages they received.

Other

Drug and device firms paid $6.5B to care providers

From research dollars to free lunches and junkets, drug and medical device companies paid doctors and leading hospitals nearly $6.5 billion last year, according to government data posted Tuesday.

Medications

US appeals court upholds delay in Alzheimer's drug swap

A federal appeals court has rejected a drug manufacturer's appeal and affirmed a judge's order that Actavis PLC keep distributing its widely used Alzheimer's medication until after its patent expires this summer.

Health

Judge says Vermont law on genetically modified food stands

A Vermont law that could make the state the first in the country to require labeling of genetically modified food has been allowed by a federal judge to stand for now despite opposition by food industry groups.

page 29 from 40